Hydroxypropyl methylcellulose/graphene oxide composite as drug carrier system for 5‐fluorouracil

Mohamed S. Hasanin,Mohamed El‐Sakhawy,Hanaa. Y. Ahmed,Samir Kamel
DOI: https://doi.org/10.1002/biot.202100183
2022-01-22
Biotechnology Journal
Abstract:Aim: This study aims to prepare green nanocomposite (HPMC/5-FL@GO) from the most biocompatible materials, hydroxypropyl methylcellulose (HPMC) and graphene oxide (GO), to enhance the drug activity of immobilized 5- Fluorouracil (5-FU) with decreasing the side effect of long-run treatment protocols with highly efficient drug-drug activity. Method and results: Different samples were characterized by ATR-FTIR spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM) coupled with energy dispersive X-ray analysis (EDX), transmission electron microscopy (TEM), Thermogravimetric analysis (TGA), and dynamic light scattering (DLS) along with cytotoxicity and anticancer study. A homogenous and compatible nanocomposite structure with a homogenous drug distribution was confirmed. The results suggested that the prepared nanocomposite has a low cytotoxicity effect against normal Vero cell lines compared with 5-FU. The antitumor activities of the same nanocomposite (20.4 and 74.3 μg/ml on A549 and HepG-2) were lower than that of 5-FU (54.1and 103 μg/ml on A549 and HepG-2). Conclusion and implications: According to the attained results, the HPMC/5-FL@GO can be expected to be widely applied in a biomedical application such as cancer therapy with the unique biocompatible to human cells.This article is protected by copyright. All rights reserved
biotechnology & applied microbiology,biochemical research methods
What problem does this paper attempt to address?